Navigation Links
Kallo's EMCURx Conferred Status Of "Official EMR Pediatrics Section, OMA"
Date:11/19/2012

TORONTO, Nov. 19, 2012 /PRNewswire/ -- At the recently held Practical Pediatrics Ontario Conference on November 9th and 10th, Kallo (OTCQB: KALO) introduced EMCURx PEMR, an electronic medical record system that was specially customized for pediatric practices and work flows, and recommended by the Pediatrics Section, Ontario Medical Association (OMA) as the EMR of choice that Ontario Pediatricians should strongly consider for their practices.

"Though Ontario is the largest market in Canada for EMR, pediatricians in this province have been neglected, and forced to work with paper records or EMRs unsuitable for pediatric use. Over the past six months, Kallo's EMCURx-PEMR has been customized in consultation with the Pediatric Section, OMA," says Vince Leitao, President and COO of Kallo Inc. "Our development team has visited numerous pediatric clinics and talked to nurses, clinic administrators and pediatricians. In consultation with these healthcare providers, we have created a specialty product for specialists. We are delighted to continue to work with the Pediatric Section, OMA and provide an innovative and better product to our Pediatricians."

Dr. Hirotaka Yamashiro, Chair of the Pediatrics Section, OMA, noted that most current EMR offerings available to Ontario Pediatricians did not work well for pediatricians' unique needs. Dr Yamashiro said, "As natural leaders in excellent health care for children and youth, we approached many vendors to create an EMR that spoke to the needs of pediatricians, and were excited when Kallo stepped up to the plate and delivered this product. We anticipate that as pediatricians adopt and use this EMR, further improvements will be made to make this the best pediatrician friendly EMR product ever brought to market, and look forward to engaging Kallo's development team to reach this goal."

There are approximately 1200 pediatricians in Ontario, and until now many were hesitant to adopt EMR for their practices due to a lack of suitable products.

Kallo Inc., is a publicly traded company, listed on the OTC markets, (otcmarkets.com) stock symbol KALO.QB

Media contact:
John Cecil or Vince Leitao
416-246-9997
http://www.kalloinc.ca


'/>"/>
SOURCE Kallo Inc.
Copyright©2012 PR Newswire.
All rights reserved

Related medicine technology :

1. Kallo Announces Purchase Order For Its Specialist EMR - EMCURx
2. International Isotopes Inc. Announces Conference Call To Give An Update On The Companys General Business Status
3. FDA Grants Orphan Drug Status To Morphoteks Amatuximab (MORAb-009)
4. Dynatronics Will Request Hearing with Nasdaq Regarding Listing Status
5. Lexicon Pharmaceuticals Reports on Clinical Program Status and 2012 Third Quarter Results
6. Medical Marijuana Inc. in a Strong Market Position with Amendment 64 in Colorado, Initiative 502 in Washington and the Pending Ninth District Decision Regarding the Schedule 1 Status of Medical Marijuana on a Federal Level
7. ChemAxons JChem Cartridge Achieves Oracle Exadata Ready Status
8. Eaton Scientific Systems Confirms Acquisition and Status of Tropine 3 Patent Pending Non-Hormonal Treatment of Hot Flashes in Menopausal Women
9. Lexicon Pharmaceuticals Reports On Clinical Program Status And 2012 Second Quarter Results
10. The New Generation of Antibody Therapeutics: Current Status and Future Prospects - Overview
11. Sinovac Reports Progress in EV71 Vaccine Phase III Clinical Trial and Commercialization Preparation Status
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... Research and Markets has announced the addition of ... report to their offering. ... The World Market for Companion Diagnostics covers the world market ... the report includes the following: , World ... Region (N. America, EU, ROW), 2015-2020 , World IVD ...
(Date:6/24/2016)... June 24, 2016  Arkis BioSciences, a leading ... and more durable cerebrospinal fluid treatments, today announced ... Series-A funding is led by Innova Memphis, followed ... other private investors.  Arkis, new financing will accelerate ... the market release of its in-licensed Endexo® technology. ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... the "Pharmaceutical Excipients Market by Type (Organic Chemical ... Preservative), Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast ... The global pharmaceutical excipients ... 2021 at a CAGR of 6.1% in the forecast ...
Breaking Medicine Technology:
(Date:6/25/2016)... ... June 25, 2016 , ... As a lifelong Southern Californian, Dr. Omkar ... M.D from the David Geffen School of Medicine at UCLA. He trained in Internal ... complete his fellowship in hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... (PRWEB) , ... June 24, 2016 , ... ... Conference and Scientific Sessions in Dallas that it will receive two significant new ... the grants came as PHA marked its 25th anniversary by recognizing patients, medical ...
(Date:6/24/2016)... ... ... makers of Topricin and MyPainAway Pain Relief Products, join The ‘Business for a Fair Minimum ... by 2020 and then adjusting it yearly to increase at the same rate as the ... wage floor does not erode again, and make future increases more predictable. , The company ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... Grove Investment Group (TGIG), has initiated cultivation and processing operations at its production ... and Pahrump, Nevada. , Puradigm is the manufacturer of a complete system of ...
Breaking Medicine News(10 mins):